CD4 and ulcerative colitis: In contrast, specimens from patients with ulcerative colitis refractory to medical therapy contained significantly more CCR9 expressing CD4+ (92.6 ± 4.1%; p < 0.001) and CD8+ T-cells (34.3 ± 3.8%; p = 0.013) than non-inflamed colon.